上海医药：关于普瑞巴林胶囊获得菲律宾药品注册证书的公告

Core Viewpoint - Shanghai Pharmaceuticals has received approval from the Philippines Food and Drug Administration for the marketing of its pregabalin capsules, indicating a significant milestone for the company in expanding its product offerings in international markets [1] Group 1 - The company announced that its subsidiary, Changzhou Pharmaceutical Factory Co., Ltd., has successfully obtained a drug registration certificate for pregabalin capsules [1] - The approval marks a key step in the company's strategy to enhance its presence in the pharmaceutical market of the Philippines [1]